Off-the-Shelf Extracellular Vesicles

About EverCyte

EverCyte is a Vienna-based biotech firm leveraging human telomerase (hTERT) immortalization to create standardized, long-lived human cell lines that mimic primary cell function. Its core business revolves around two pillars: providing these cells and derived extracellular vesicles as products for research, and offering contract services in cell line development, drug screening, and gene editing. The company positions itself as an enabler for more predictive preclinical testing and scalable production of therapeutic EVs, operating primarily as a B2B platform and service provider within the regenerative medicine and cell therapy sectors.

Therapeutic Areas